Lfb : honoraires des commissaires aux comptes - exercices 2015 et 2016
<
>
Copyright Business Wire 2017LFB : HONORAIRES DES COMMISSAIRES AUX COMPTES - EXERCICES 2015 ET 2016
< >LFB
< >Regulatory News:
LFB:
| Cailliau Dedouit et Associés | PricewaterhouseCoopers Audit | |||||||||||||||
|
Montant |
HT % |
Montant |
HT % |
|||||||||||||
| Montants exprimés en milliers d'euros | ||||||||||||||||
| 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | 2016 | 2015 | |||||||||
| Audit | ||||||||||||||||
| Commissariat aux comptes, certification, examen des comptes individuels et consolidés : | ||||||||||||||||
| - LFB SA | 89 | 87 | 41% | 42% | 89 | 87 | 16% | 13% | ||||||||
| - LFB Biomédicaments SA | 59 | 58 | 27% | 27% | 59 | 58 | 11% | 9% | ||||||||
| - LFB Biotechnologies SASU | 21 | 21 | 10% | 10% | 21 | 21 | 4% | 3% | ||||||||
| - LFB Hemoderivados e Biotecnologia Ltda | - | - | - | - | 32 | 30 | 6% | 4% | ||||||||
| - LFB GmbH | - | - | - | - | - | - | - | - | ||||||||
| - LFB Middle East SA | - | - | - | - | 0 | 5 | 0% | 1% | ||||||||
| - LFB Biopharmaceuticals Ltd | - | - | - | - | 0 | 0 | 0% | 0% | ||||||||
| - LFB Biomanufacturing SASU | 25 | 24 | 11% | 11% | - | - | - | - | ||||||||
| - LFB Global Plasma SASU | 3 | 3 | 2% | 1% | - | - | - | - | ||||||||
| - CellforCure SASU | 18 | 18 | 8% | 8% | - | - | - | - | ||||||||
| - rEVO Biologics Inc. | - | - | - | - | 136 | 306 | 25% | 45% | ||||||||
| - LFB USA Inc. | - | - | - | - | 93 | 93 | 17% | 14% | ||||||||
| - CAF-DCF bvba-sprl | - | - | - | - | 37 | - | 7% | - | ||||||||
| - Groupe Europlasma | - | - | - | - | 50 | 50 | 9% | 7% | ||||||||
| Sous-total certification des comptes | 215 | 209 | 99% | 100% | 517 | 649 | 96% | 96% | ||||||||
| Juridique, fiscal, social | 3 | 0 | 1% | 0% | - | - | - | - | ||||||||
| Autres | - | - | - | - | 22 | 25 | 4% | 4% | ||||||||
| Sous-total Autres diligences et prestations | 3 | 0 | 1% | 0% | 22 | 25 | 4% | 4% | ||||||||
| TOTAL | 218 | 209 | 100% | 100% | 539 | 674 | 100% | 100% | ||||||||
Consultez la version source sur businesswire.com : http://www.businesswire.com/news/home/20170427006094/fr/